NCT06554392
Identification of Serum Level of Glutathione Peroxidase 4
At risk: Primary completion moved 12 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Primary completion pushed from Sep 1, 2026 to Sep 1, 2027 Show 5 more changesShow less
- Recruitment opened
- Eligibility criteria expanded, about 6 words
- Study completion pushed from Jul 1, 2027 to Jul 1, 2028
- Study sites: 0 to 1
- Publications: details revised at 5 of 5 entries
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Analysis of the serum level of glutathione peroxidase 4 (GPX4) in ankylosing spondylitis and axial psoriatic arthritis patients.
Timeframe: baseline
Secondary (1)
The association of glutathione peroxidase 4 (GPX4) with disease activity and severity in ankylosing spondylitis and axial psoriatic arthritis patients.
Arms and interventions
Ankylosing Spondylitis patients
Identification of Glutathione Peroxidase 4 in blood.
Axial Psoriatic Arthritis Patients
Identification of Glutathione Peroxidase 4 in blood.
healthy controls
Identification of Glutathione Peroxidase 4 in blood.
Diagnostic tests: Blood sample
Sites
1 site in 1 country
- Faculty of Medicine- Assiut UniversityAsyut, Egypt